Jincai Internet's blockchain

1.

1.002657 Zhongke Jincai

2.300663 Kelan software

3.002152 radio and television express

4.300079 digital technology

5.300542 Xinchen technology

6.600570 Hengsheng electronics

< P > 7.300561 Huijin technology

8.002063 high beam software

9.603106 Hengyin finance

blockchain concept stocks may become the leading stocks as follows:

1. Blockchain concept stock 1: easy to see stock (600093. SH) concept stock index

the company's main supply chain management has been actively transforming in recent years. On the one hand, the company strives to improve the business scale of supply chain management and commercial factoring

on the other hand, with the transformation of financial technology as the center and the application of blockchain technology in supply chain finance as the breakthrough, the whole policy has made every effort to promote the development of the "easy to see block" system. In the first half of 2017, the development of the "easy to see block" System 1.0 has been successfully completed, and it has been commercialized in the fields of medicine and large commodities

2. Blockchain concept stock 2: gawaita

is a leading financial information manufacturer in China. Relying on its own advantages in bank IT solutions and bank customer resources, gawaita provides bank it system cloud services

3, blockchain concept stock 3: Xinchen technology is mainly engaged in application software development business, software and hardware system integration business and professional technical service business. In recent years, Xinchen technology has made bold attempts in innovation. The company has made some progress in the application of new technologies such as cloud computing, big data, artificial intelligence and blockchain in the financial instry

the domestic L / C business system based on blockchain technology has been successfully launched in banks, and is expected to graally become a new growth point of the company's software solution business

< H2 > extended data:

the leading stock index is the stock that has influence and appeal on other stocks in the same instry ring the stock market speculation in a certain period, and its rise and fall often play a guiding and exemplary role in the rise and fall of other stocks in the same instry

leading stock is not unchangeable, its status can only be maintained for a period of time. The basis of becoming a leading stock is that any information related to a stock will be immediately reflected in the stock price

conditions for leading stocks:

1. Leading stocks must start from the trading board, which is the most accurate attack signal for both sides. Indivial stocks that can't be trading can't be leading stocks.

2. Leading stocks are the best low price stocks, and low price stocks are sought after by many investors, because high price stocks are difficult to speculate

3. The circulation market of leading stocks should be moderate, suitable for large capital operation and retail investors chasing up and down, and large market value stocks and small cap stocks can not be the leader

4. Leading stocks meet the daily KDJ, weekly KDJ and monthly KDJ at the same time

5. Leading stocks usually rise against the market limit at the end of market decline when the market panics, or start ahead of the market, and undergo a round of market decline test

the leading stock index is the stock that has influence and appeal on other stocks in the same instry ring the stock market speculation in a certain period, and its rise and fall often play a guiding and exemplary role in the rise and fall of other stocks in the same instry. Leading stock is not immutable, its status can only be maintained for a period of time

< H2 > reference: network leading stocks

5.

To solve the problem, we should first understand the digital background of Jincai Internet, which is called cloud alliance :

enterprise development stage

① enterprise internal management ERP -- ② e-commerce and social network -- ③ mobile Internet Comprehensive connection

the change of enterprise marketing way

① channel is the king -- ② flow is the king -- ③ gather people to be the king

after understanding these backgrounds, you will probably know the problems that I cloud alliance should solve:

① provide SCRM service for enterprise management, employee management, performance

(2) for customer service, we can build user portrait, label management and improve service efficiency

③ for marketing, Omni channel marketing on cable and offline can achieve precision and scene, real-time analysis of store operation status and optimization of marketing strategy

(4) for expanding business, it can help enterprises to open small program stores and have a complete set of perfect sales system

6. If you have any difficulties, you can sit down with your friends and relatives and talk about how you can turn around as much as possible. If you do, you can increase your trust. It's better than the interest you give to the net bag for nothing, and it's better than the one who can't support the loan and sink deeper and deeper in the future; If even your relatives and friends are not willing to help you, how can these outsiders on the Internet be reliable. In fact, no matter what, as long as you ask for money, password, verification code, payment password, or the other party asks you to log in some accounts provided by the other party on your mobile phone, or ask you to deposit in your own credit card, you will never be trusted. If you really have no way, you can download the Internet app such as Suning finance, Jiufu wanka, paipai loan, Zhaolian finance, etc.

7. List of biological vaccine concept stocks
China animal husbandry (600195) Co., Ltd. is the first bird flu vaccine manufacturer approved by the Ministry of agriculture of the people's Republic of China
Rhine bio (002166) company's business includes extracting and manufacturing & quot; Tamiflu & quot; Shikimic acid, the raw material of the proct
the influenza vaccine developed by Haiwang intelon, a subsidiary of Haiwang biological (000078) company, is the second generation influenza vaccine in the world and the first in China
Daan gene (002030) Co., Ltd. and its joint venture Guangzhou huashengda Co., Ltd. have jointly developed a new human influenza A (H1N1) virus nucleic acid detection kit and a universal influenza A virus nucleic acid detection kit, and have obtained the registration certificate of medical devices for influenza A (H1N1) virus detection kit. In the national key new proct plan issued by the Ministry of science and technology, the company's influenza A (H1N1) virus nucleic acid detection kit (PCR fluorescent probe method) (No. 2010gre01001) was confirmed as a national key new proct
the proct group of Northeast Pharmaceutical (000597) company covers more than 200 kinds of seven categories, including vitamins, anti infection, family planning and hormone, antiviral, brain circulation and intelligence promoting drugs, digestive system, anesthesia and psychiatry< Beijing Sihuan biopharmaceutical Co., Ltd., a subsidiary of Sihuan bio (000518), is the first high-tech enterprise in China to engage in the research, pilot test, proction and sales of genetic engineering drugs and diagnostic reagents, integrating science, instry and trade.
Lukang Pharmaceutical (600789) Co., Ltd., one of the antibiotic proction bases in China, is an enterprise with a relatively complete proction chain of three major parent nuclei of semi synthetic antibodies, The company has also realized the transformation from traditional antibiotic proction to haploidentical antibody proction. The Inner Mongolia biopharmaceutical factory of Jinyu group (600201) company is the only enterprise procing livestock and poultry vaccine procts in the autonomous region.
shenghuake (600226) company is a recessive leading enterprise in the domestic pesticide, veterinary medicine, animal vaccine and zirconium instries. Its main veterinary medicine procts cover three major fields: animal vaccine, animal antibiotic preparation and animal nutrition medicine, with complete instrial chain, The competition ability is outstanding
Lianhuan Pharmaceutical (600513) Co., Ltd. already has inactivated avian influenza vaccine (H9 subtype, f strain), which has obtained the veterinary drug proction approval from the Ministry of agriculture and has been put into proction
puluokangyu Co., Ltd. is the largest manufacturer of raw materials and preparations for amantadine and rimantadine, the anti avian influenza drugs in China, and the only company that can proce this tablet in the current market, The drug has been listed in the national influenza reserve
Hualan biological (002007) Co., Ltd. and Chinese Academy of Military Medical Sciences jointly undertake the pre clinical research of human avian influenza vaccine. After the verification and evaluation, the company's pandemic influenza split vaccine will enter the clinical stage
Beijing Institute of biological procts and Chinese Academy of Military Medical Sciences, the controlling shareholders of Tiantan Biological (600161) Co., Ltd., will jointly undertake the research and development of the second human avian influenza vaccine project in mainland China

8. Flash bull analysis: Changchun hi tech: Changchun hi tech instry (Group) Co., Ltd. was established in June 1993. Its shares were listed on the main board of Shenzhen Stock Exchange on December 18, 1996, becoming one of the earliest listed companies in Northeast China. The company's main business is biopharmaceutical, Chinese patent medicine proction and sales, supplemented by real estate development, property management, etc< Chongqing Zhifei Biological Procts Co., Ltd. was established in 1995 and listed on the Shenzhen Stock Exchange on September 28, 2010. With a registered capital of 400 million yuan, the company has three wholly-owned subsidiaries, including high-tech enterprises Beijing Lvzhu biopharmaceutical Co., Ltd., Anhui longkema biopharmaceutical Co., Ltd. and Chongqing Zhiren Biotechnology Co., Ltd. It is a biological high-tech enterprise integrating vaccine R & D, proction and sales
Kangtai biological: Shenzhen Kangtai Biological Procts Co., Ltd., established in August 1988, is one of the high-tech enterprises in Shenzhen, mainly engaged in the R & D, proction and sales of biological procts. In 2008, Kangtai biological carried out strategic capital restructuring. In October 1987, the State Planning Commission approved that the Ministry of health should organize the introction of instrial proction technology of genetically engineered recombinant (yeast) hepatitis B vaccine for construction in Beijing and Shenzhen
Watson Biotechnology: Yunnan Watson Biotechnology Co., Ltd. is a biopharmaceutical enterprise specializing in the R & D, proction and sales of human vaccine procts, and is committed to providing safe, effective, high-quality and advanced human vaccine procts to domestic and foreign markets. On November 12, 2010, Yunnan Watson Biotechnology Co., Ltd. was successfully listed on Shenzhen Stock Exchange, becoming the first enterprise in Yunnan Province to be listed on China growth enterprise market
Hualan Bioengineering: Hualan Bioengineering Co., Ltd., formerly known as Hualan Bioengineering Co., Ltd., was established in 1992. It is a national key high-tech enterprise engaged in research and development and proction of blood procts, and was the first to pass GMP certification in the blood procts instry in 1998. As a national designated large-scale biological procts proction enterprise, the company has undertaken a number of national, provincial and municipal scientific and technological projects.